This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Morris Kletzel, MD; Suzanne Beck, MD; Joe Elser, MD; Nikki Shock, MSS; Wesley Burks, MD

Am J Dis Child. 1991;145(12):1428-1429.

Abstract
• Hemophiliacs infected with human immunodeficiency virus with a history of hypersensitivity reaction to a combination product of trimethoprim and sulfamethoxazole were desensitized orally. Six of the seven patients included in the study successfully completed the desensitization protocol and received trimethoprim-sulfamethoxazole for 5 to 7 months after desensitization (mean length of treatment, 5.7 months) for prophylaxis of Pneumocystis carinii pneumonia. The small number of patients and the short follow-up allow us to suggest that oral desensitization may be an effective and inexpensive means to treat hemophiliacs infected with human immunodeficiency virus with trimethoprim-sulfamethoxazole as prophylaxis against Pneumocystis carinii pneumonia.

(AJDC. 1991;145:1428-1429)

Author Affiliations
From the Department of Pediatrics, University of Arkansas for Medical Sciences and Arkansas Children's Hospital, Little Rock. Dr Kletzel is now with the Department of Pediatrics, Children's Memorial Hospital, Chicago, Ill.

Footnotes
Accepted for publication July 8, 1991.

Reprint requests to Northwestern University, Children's Memorial Hospital, 2300 Children's Plaza, Chicago, IL 60614 (Dr Kletzel).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?